As of 20 June 2025, the Health Technology Assessment (HTA) Council has completed the evidence appraisal on the assessment of newborn pulse oximetry as a screening test for critical congenital heart disease (CCHD) among asymptomatic, apparently healthy newborns for possible government financing. The HTA Council hereby releases its preliminary recommendation on the said health technology continue reading : HTA Council Preliminary Recommendation on Newborn Pulse Oximetry as a Screening test for critical congenital heart disease (CCHD) among asymptomatic, apparently healthy newborns
HTA Council Preliminary Recommendation on Tuberculosis Diagnostic Tests
As of 19 June 2025, the Health Technology Assessment Council has completed the evidence appraisal on the assessment of the following health technologies for possible government financing: These health technologies were reviewed against clinical practice guidelines (CPGs) [local and approved by the DOH, such as the DOH Omnibus Health Guidelines (OHG); and/or international, but locally continue reading : HTA Council Preliminary Recommendation on Tuberculosis Diagnostic Tests
HTA Council Preliminary Recommendation on Japanese Encephalitis Vaccine (JEV)
Update as of 13 June 2025 : Since the public consultation and appeals period for the HTA Council Preliminary Recommendation on Japanese encephalitis vaccine for the prevention of Japanese encephalitis among children 9 to 59 months old in high risk areas ended on 10 June 2025 without any appeals received, this preliminary HTA Council recommendation lapsed into the Final continue reading : HTA Council Preliminary Recommendation on Japanese Encephalitis Vaccine (JEV)
HTA Council Preliminary Recommendation on Human Immunodeficiency Virus (HIV) Self Test Kit, HIV/Syphilis Duo Test, In Vitro Quantitative HIV Nucleic Acid Test (HIV-NAT 1), and Silver Diamine Fluoride 38% Clear Topical Solution
Update as of 18 June 2025 : Since the public consultation and appeals period for the HTA Council Preliminary Recommendation on these health technologies ended on 10 June 2025 without any appeals received, this preliminary HTA Council recommendation lapsed into the Final Recommendation and was transmitted on 18 June 2025 to the Secretary of Health, pending decision. As of 26 continue reading : HTA Council Preliminary Recommendation on Human Immunodeficiency Virus (HIV) Self Test Kit, HIV/Syphilis Duo Test, In Vitro Quantitative HIV Nucleic Acid Test (HIV-NAT 1), and Silver Diamine Fluoride 38% Clear Topical Solution
HTA Council Preliminary Recommendation on Ceftaroline Fosamil (600 mg powder for concentrate for solution for injection) in the Treatment of Community-Acquired Pneumonia (CAP) in Children
Update as of 14 May 2025 : Since the public consultation and appeals period for the HTA Council Preliminary Recommendation on Ceftaroline Fosamil (600 mg powder for concentrate for solution for injection) in the Treatment of Community-Acquired Pneumonia (CAP) in Children ended on 13 May 2025 without any appeals received, this preliminary HTA Council recommendation lapsed into the Final continue reading : HTA Council Preliminary Recommendation on Ceftaroline Fosamil (600 mg powder for concentrate for solution for injection) in the Treatment of Community-Acquired Pneumonia (CAP) in Children